Cardlytics Inc

For the period ended Dec 31, 2024. Filed Mar 12, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 12, 2025

CDLX$1.82-6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(Amounts in thousands, except per share amounts)

	Year Ended December 31,
	2024	2023	2022
Revenue	$278,298	$309,204	$298,542
Costs and expenses:
Partner Share and other third-party costs	127,761	150,578	155,507
Delivery costs	29,643	28,248	30,403
Sales and marketing expense	52,649	57,425	74,745
Research and development expense	49,607	51,352	54,435
General and administrative expense	56,482	58,810	81,446
Acquisition, integration and divestiture costs (benefits)	161	(6,313)	(2,874)
Change in contingent consideration	210	1,246	(128,174)
Impairment of goodwill and intangible assets	131,595	70,518	453,288
Loss on divestiture	—	6,550	—
Depreciation and amortization expense	25,689	26,460	37,544
Total costs and expenses	473,797	444,874	756,320
Operating loss	(195,499)	(135,670)	(457,778)
Other income (expense):
Interest expense, net	(5,553)	(2,336)	(2,556)
Foreign currency (loss) gain	(1,269)	3,304	(6,376)
Gain on debt extinguishment	13,017	—	—
Total other income (expense)	6,195	968	(8,932)
Loss before income taxes	(189,304)	(134,702)	(466,710)
Income tax benefit	—	—	1,446
Net Loss	(189,304)	(134,702)	(465,264)
Net loss per share, basic and diluted	$(3.91)	$(3.69)	$(13.92)
Weighted-average common shares outstanding, basic and diluted	48,361	36,488	33,419

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.